Clinical Trial Update: Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the relative bioavailability of a pediatric powder-for-suspension formulation (PfOS); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED